期刊文献+

复方阿嗪米特联合新洛纳治疗糖尿病胃肠病48例的疗效观察 被引量:3

下载PDF
导出
摘要 目的评价复方阿嗪米特肠溶片联合新洛纳治疗糖尿病胃肠病变的疗效。方法48例诊断为糖尿病胃肠病变的患者,给予复方阿嗪米特肠溶片以及新洛纳,观察其疗效。结果48例糖尿病胃肠病患者经治疗2周和4周,腹胀症状的改善明显优于治疗前,且随着治疗时间延长到4周,患者胃肠病变的主要症状得到更明显的改善。结论复方阿嗪米特肠溶片联合新洛纳治疗糖尿病胃肠病变中胃轻瘫、腹泻有明显疗效。对便秘亦有一定的疗效。
出处 《四川医学》 CAS 2010年第4期530-531,共2页 Sichuan Medical Journal
  • 相关文献

参考文献2

二级参考文献15

  • 1陈思维,薛淑英,王敏伟.介绍一种简易实验性胃排空测定方法[J].中国药理学通报,1994,10(4):317-317. 被引量:14
  • 2施新猷.动物实验的基本技术操作方法[A].见:施新猷主编.医学动物实验方法[C].北京:人民卫生出版社,1980.103-104.
  • 3Thomas AR, Chan LN, Bauman JL, Olopade CO. Prolongation of the QT interval related to cisapride-diltiazem interaction. Pharmacotherapy, 1998, 18: 381~385.
  • 4Mine Y, Yoshikawa T, Oku S, Nagai R, Yoshida N,Hosoki K. Comparison of effect of mosapride citrate and existing 5-HT4 receptor agonists on gastrointestinal motility in vivo and in vitro. J Pharmacol Exp Ther, 1997, 283:1000~1008.
  • 5Yoshida N, Omoya H, Oka M, Furukawa K, Ito T, Karasawa T. AS-4370, a novel gastrokinetic agent free of dopamine D2 receptor antagonist properties. Arch Int Pharmacodyn Ther, 1989, 300: 51~67.
  • 6Yoshida N. Pharmacological effects of the gastroprokinetic agent mosapride citrate. Nippon Yakurigaku Zasshi,1999, 113: 299~307.
  • 7Carlsson L, Amos GJ, Andersson B, Drews L, Duker G,Wadstedt G. Electrophysiological characterization of the prokinetic agents cisapride and mosapride in vivo and in vitro: implications for proarrhythmic potential? J Pharmacol Exp Ther, 1997, 282: 220~227.
  • 8Kii Y, Ito T. Effects of 5-HT4-receptor agonists, cisapride,mosapride citrate, and zacopride, on cardiac action potentials in guinea pig isolated papillary muscles. J Cardiovasc Pharmacol, 1997, 29: 670~675.
  • 9Sakurai-Yamashita Y, Yamashita K, Kanematsu T,Taniyama K. Localization of the 5-HT4 receptor in the human and the guinea pig colon. Eur J Pharmacol, 1999,383: 281~285.
  • 10Taniyama K, Makimoto N, Furuichi A, Sakurai-Yamashita Y, Nagase Y, Kaibara M, Kanematsu T. Functions of peripheral 5-hydroxytryptamine receptors, especially 5-hydroxytryptamine4 receptor, in gastrointestinal motility. J Gastroenterol, 2000, 35: 575~582.

共引文献126

同被引文献20

  • 1蒋新建,李彦晞.泌特联合奥为仙治疗糖尿病胃肠病96例的疗效观察[J].医学信息(医学与计算机应用),2014,0(19):450-450. 被引量:2
  • 2Duby J J,Campbll R K,Setter S M,et al.Diabetic neuropathy:an intensive review[J].Am J Health Syst Pharm,2004,61(2):160-176.
  • 3Kassander P.Asymtomatic gastric retention in diabetic[J].Ann Intern Med,1958,48(4):707-812.
  • 4Stehouwer C D,Lanbert J,Donker A J,et al.Endonthelialdys-Function and pathogens is diabetic angiopathy[J].Canliovasc Res,1997,34(1):55-56.
  • 5Yanagisawa H,Kurihara H,Kiuura S,et al.A novel portent vasoconstor petide produced by vasculcur endothelial cell[J].Nature,1988,332(3):411-412.
  • 6Kinlay S,Peter G.Role of endothelial dysfunction in coronary artery disease and implication for therapy[J].Am J Cardiol,1997,80(2):111-112.
  • 7国家医药管理局编委会.中华本草上册[M].上海:上海科学技术出版社,1998:896.
  • 8Choung RS, Locke GR 3rd, Schleck CD, et al. Risk of gastropare- sis in subjects with type 1 and 2 diabetes in the general population. Am J Gastmenterol. 2012 Jan;107( 1 ) :82-88.
  • 9Boas M, Kislov J, Dickman R, WainsteinJ. Obesity and symptoms suggestive of gastroparesisin patients with type 2 diabetes and neu- ropathy. J Diabetes Complications. 2011 Sep-Oct; 25 ( 5 ) : 325-328.
  • 10Bures J, Smahelov6 A, Tachecl I, etal. Motility disorders and gas- tric emptying in diabetes mellitus. Current diagnostics and treat- merit. VnitrLek. 2011 Apt;57(4) :351- 355.

引证文献3

二级引证文献6

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部